Search by Drug Name or NDC

    NDC 42291-0258-10 Doxazosin 2 mg/1 Details

    Doxazosin 2 mg/1

    Doxazosin is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is DOXAZOSIN MESYLATE.

    Product Information

    NDC 42291-0258
    Product ID 42291-258_0e8c58bf-d628-5974-e063-6294a90a1a99
    Associated GPIs 36202005100320
    GCN Sequence Number 015585
    GCN Sequence Number Description doxazosin mesylate TABLET 2 MG ORAL
    HIC3 J7B
    HIC3 Description ALPHA-ADRENERGIC BLOCKING AGENTS
    GCN 33432
    HICL Sequence Number 006031
    HICL Sequence Number Description DOXAZOSIN MESYLATE
    Brand/Generic Generic
    Proprietary Name Doxazosin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Doxazosin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2
    Active Ingredient Units mg/1
    Substance Name DOXAZOSIN MESYLATE
    Labeler Name AvKARE
    Pharmaceutical Class Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075580
    Listing Certified Through 2025-12-31

    Package

    NDC 42291-0258-10 (42291025810)

    NDC Package Code 42291-258-10
    Billing NDC 42291025810
    Package 1000 TABLET in 1 BOTTLE (42291-258-10)
    Marketing Start Date 2015-04-09
    NDC Exclude Flag N
    Pricing Information N/A